Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, Korea.
Gut Liver. 2022 Nov 15;16(6):942-951. doi: 10.5009/gnl210415. Epub 2022 May 25.
BACKGROUND/AIMS: Chronic enteropathy associated with gene (CEAS), an inherited disease characterized by nonspecific intestinal ulcers, has emerged in the Japanese population via loss-of-function mutations in the gene. We aimed to investigate the clinical and genetic characteristics of Korean patients diagnosed with CEAS.
From July 2018 to July 2021, we performed Sanger sequencing of the gene in 46 patients with chronic intestinal ulcers. CEAS was confirmed based on known mutations. We summarized the clinical characteristics of patients with confirmed CEAS.
Fourteen out of 46 patients (30.4%) had genetically confirmed CEAS, and two variants were detected (splicing site variant c.940+1G>A and nonsense mutation [p.R603X] in ). Twelve patients (85.7%) were females and the median age at diagnosis of CEAS was 44.5 years. All patients presented with abdominal pain, and 13 patients (92.9%) presented with anemia (median hemoglobin, 9.6 g/dL). Ten patients (71.4%) had hypoalbuminemia (median, 2.7 g/dL). The most commonly involved site was the ileum (13/14, 92.9%). Manifestations of primary hypertrophic osteoarthropathy (PHO), such as digital clubbing, pachydermia, and periostosis were observed in five patients (28.6%) and two male patients and one female patient satisfied all major PHO diagnostic criteria.
The clinical and genetic characteristics of Korean patients with confirmed CEAS were similar to those reported in the literature. CEAS should be considered in the differential diagnosis for patients with unexplained chronic nonspecific ulcers of the small intestine.
背景/目的:慢性肠炎伴 基因(CEAS)是一种遗传性疾病,其特征为非特异性小肠溃疡,在日本人群中通过 基因的功能丧失突变而出现。我们旨在研究诊断为 CEAS 的韩国患者的临床和遗传特征。
自 2018 年 7 月至 2021 年 7 月,我们对 46 例慢性肠溃疡患者进行了 基因的 Sanger 测序。根据已知的 突变,确认 CEAS。我们总结了确诊 CEAS 患者的临床特征。
46 例患者中有 14 例(30.4%)经基因证实患有 CEAS,检测到两种 变异(剪接位点变异 c.940+1G>A 和无义突变 [p.R603X])。12 例患者(85.7%)为女性,CEAS 的确诊年龄中位数为 44.5 岁。所有患者均有腹痛,13 例(92.9%)有贫血(中位血红蛋白 9.6 g/dL)。10 例(71.4%)有低白蛋白血症(中位数 2.7 g/dL)。最常受累的部位是回肠(13/14,92.9%)。5 例(28.6%)患者和 2 例男性患者和 1 例女性患者出现原发性肥大性骨关节病(PHO)的表现,如杵状指、厚皮症和骨膜骨形成。
韩国确诊 CEAS 患者的临床和遗传特征与文献报道相似。对于不明原因的小肠非特异性慢性溃疡患者,应考虑 CEAS 作为鉴别诊断。